SCHEMBL10012355

SCHEMBL10012355

COC(=O)C(OC(C)=O)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.42
TDP1 Q9NUW8 1/20 0.37
CA14 Q9ULX7 2/20 0.36
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
TBXA2R P21731 1/20 0.34
LMNA P02545 2/20 0.33
KMT2A Q03164 2/20 0.33
CA12 O43570 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
HRH1 P35367 1/20 0.33
GALR3 O60755 1/20 0.33
MAPT P10636 1/20 0.33
BLM P54132 1/20 0.33
TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10011638 0.80 SMN1; SMN2 (0.43) ALDH1A1TSHRSMN1; SMN2CA14KMT2A
SCHEMBL10011167 0.78 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL10890005 0.76 MGAM (0.42) ALDH1A1TSHRSMN1; SMN2CA14LMNA
SCHEMBL5864497 0.76 TSHR (0.50) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL8004094 0.76 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL866170 0.76 TSHR (0.50) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL15945450 0.74 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL6447990 0.74 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL9839802 0.74 SMN1; SMN2 (0.44) ALDH1A1TSHRSMN1; SMN2TDP1CA14
SCHEMBL29103901 0.74 ALDH1A1 (0.55) ALDH1A1TSHRSMN1; SMN2TDP1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed
US-7241402-B2 Organic positive temperature coefficient thermistor TDK CORPORATION (JP) 2007-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 ALDH1A1 2965/4885TSHR 3669/4885SMN1; SMN2 4063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.